Evaluation of oxidative stress and antioxidant status in patients with diabetes mellitus

Journal of Applied Sciences Research

Volumn 5, Issue 7, 2009, Pages 770-775

  Pasupathi, Palanisamy ^a   Bakthavathsalam, Govindasamy ^b   Saravanan, Ganesan ^c   Latha, Raman ^c  

^a Institute of Laboratory Medicine   (India)

^b ANNAMALAI UNIVERSITY   (India)

^c KG Hospital and Post Graduate Medical Institute   (India)

Author keywords

Antioxidant status; Diabetes mellitus; Lipid peroxidation; Oxidative stress

Indexed keywords

EID: 70349389350     PISSN: 1816157X     EISSN: 1819544X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wild, S., G. Roglic, A. Green, R. Sicree and H. King, 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabet. Care, 27: 1047-1053.
2. Tiwari, A.K. and J. Madhusudana Rao, 2002. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Current Science, 83: 30-38.
3. Sheetz, M.J. and G.L. King, 2002. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA, 288: 2579-2588.
4. Preet, A., B.L. Gupta, P.K. Yadava and N.Z. Baquer, 2005. Efficacy of lower doses of vanadium in restoring altered glucose metabolism and antioxidant status in diabetic rat lenses. J. Bioscience, 30: 221-230.
5. Halliwell, B. and M. Whiteman, 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. British Journal of Pharmacology, 142: 231-255.
6. Halliwell, B., 2001. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging, 18: 685-716.
7. Donne, I.D., R. Ranieri, C. Roberto, G. Daniela and M. Aldo, 2006. Biomarkers of oxidative damage in human disease. Clinical Chemistry, 52: 601-623.
8. Donald, D.H., 2005. Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 26: 689-695.
9. Steinberg, D., S. Parathasarathy, T.E. Carew, J.C. Khow and J.L. Witatum, 1989. Modifications of low-density lipoproteins that increase its atherogenicity. NEJM, 20: 915-918.
10. Stringer, M.D., P.G. Gorog, A. Freeman and V.V. Kakkar, 1989. Lipid peroxides and atherosclerosis. BMJ, 298: 281-285.
11. Mullarkey, C.J., D. Edelstein and L. Brownlee, 1990. Free radical generation by early glycation p ro d u c ts: a me chanism for a c c e le r a te d atherogenesis in diabetes. Biochem. Biophys. Res. Comm., 173: 932-939.
12. Mahboob, M., M.F. Rahman and P. Grover, 2005. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. SMJS, 46: 322-324.
13. Xi, L.S., H.F. Fan, G.Z. Jian, N. Ryoji, Z.W. Ru, L.Z. Qiang, Z.Z. Mei, Z. Mei, D. Xie, W.G. Bao, and Z. Xun, 2006. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 26: 1156-1162.
14. Firoozrai, M., M. Nourbakhsh and M. Razzaghy-Azar, 2007. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Research and Clinical Practice, 77, 427-432.
15. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18:499-502.
16. Yagi, K., 1978. Lipid peroxides and human diseases. Chem. Phys. Lipids, 45: 337-351.
17. Kakkar, P.S., B. Das and P.N. Viswanathan, 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys., 21: 130-132.
18. Sinha, K.A., 1972. Colorimetric assay of catalase. Anal. Biochem, 47: 389-394.
19. Rotruck, J.T., A.L. Pope, H.E. Ganther, A.B. Swanson, D.G. Hafeman and W.G Hoekstra, 1973. Selenium: biochemical roles as a component of glutathione peroxidase. Science, 179: 588-590.
20. Ellman, G.L., 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82:70-77.
21. Habig, W.H., M.J. Pabst and W.B. Jakoby, 1974. Glutathione-S-transferases, the first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130-7139.
22. Lowry, O.H., M.J. Rosenbrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with Folin-Phenol reagent. Journal of Biological Chemistry, 193: 265-275.
23. Bradley, D.W. and C.L. Hombeck, 1973. Clinical evaluation and improved TFA micro method for plasma and serum vitamin (A) b-carotein. Biochem. Med., 7: 78-86.
24. Baker, H., O. Frank, B. De Angelis and S. Feingold, 1980. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr. Rep. Int., 21: 531- 536.
25. Roe, H.J. and C.A. Kuether, 1943. Detection of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenyl-hydrazine derivative of dehydro ascorbic acid. J. Biol. Chem., 147: 399- 407.
26. American Diabetes Association, 2005. Diagnosis and classification of diabetes mellitus. Diab.Care, 28 (Suppl.): 37- 42.
27. Gloria-Botthini, F., E. Antonacci, N. Bottini, A. Ogana, P. Borgiani, G. De Santis and N. Lucarini, 2000. Rh blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level. Hum. Bio., 72: 287-294.
28. Sampson, M.J., D.A. Hughes, M.J. Carrier and I.R. Davies, 2002. Status of HbA1c during acute hyperglycemia in type 2 diabetes. Diabetes care, 25: 537-541.
29. Prakasam, A., S. Sethupathy and K.V. Pugalendi, 2004. Influence of Casearia esculenta root extract on protein metabolism and marker enzymes in streptozotocin-induced diabetic rats. Pol. J. Pharmacol. Pharm., 56: 587-593.
30. Venkateswaran, S., L. Pari and G. Saravanan, 2002. Effect of Phaseolus vulgaris on circulatory antioxidants and lipids in rats with streptozotocininduced diabetes. J.Medicinal Food, 5: 97-103.
31. Suryawanshi, N.P., A.K. Bhutey, A.N. Nagdeote, A.A. Jadhav and G.S. Manoorkar, 2006. Study of lipid peroxide and lipid profile in diabetes mellitus. Indian Journal of Clin. Biochem., 21: 126-130.
32. Kuyvenhoven, J.P. and A.E. Meinders, 1999. Oxidative stress and diabetes mellitus pathogenesis of long-term complications. EJIM, 10: 9-19.
33. Ramachandran, B., K. Ravi, V. Narayanan, M. Kandaswamy and S. Subramanian, 2004. Effect of macrocyclic binuclear oxovanadium complex on tissue defense system in streptozotocin-induced diabetic rats. Clinca Chimica Acta, 345: 141-150.
34. Sozmen, E.Y., B. Sozmen, Y. Delen and T. Onat, 2001. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Archives of Medical Research, 32: 283-287.
35. Rathore, N., M. Kale, S. John and D. Bhatnagar, 2000. Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat erythrocytes. Indian J. Physio. Pharmaco, 44: 161-166.
36. Ford, E.S., J.C. Will, B.A. Bowman and K.M. Venkat Narayan, 1999. Diabetes mellitus and serum carotenoids: findings from the third national health and nutrition examination survey. Am. J. Epidemiol., 149: 168-176.
37. Basu, T.K., C. Basualdo, 1997. Vitamin A homeostasis and diabetes mellitus. Nutrition, 13: 804-806.